Skip to main content Start main content

Academic Staff

People
Dr Sai Wang Seto
PolyU Scholars Hub

Dr Seto Sai-wang

Associate DoRCMI & Assistant Professor

Research Overview

Our group is interested in the discovery of novel therapeutic targets for complex and multi-factorial health problems.

Education and Academic Qualifications

  • Bachelor of Science, The University of Liverpool
  • Doctor of Philosophy, The Chinese University of Hong Kong

Professional Qualifications

  • British Pharmacological Society - Member
  • Royal Pharmacological Society - SRPharmS
  • NICM Health Research Institute, Western Sydney University - Adjunct Fellow

Research Interests

  • Pharmacology
  • Bone-derived Proteins and Vascular Diseases
  • Chinese Herbal Medicine for Cerebrovascular Diseases

Achievements

  • Young Investigator Award (2008) - Institute of Cardiovascular Science and Medicine - 12th Annual Scientific Meeting, Hong Kong
  • Australian Government National Health and Medical Research Council (NHMRC) Training Fellowship (2011-2012)
  • National Heart Foundation (NHF) Postdoctoral Fellowship (2013-14)
  • National Heart Foundation (NHF) of Australia – Exchange and Collaboration Award (2013)
  • Cardiac Health Institute Research Fellowship (2015-2020)
  1. He L, Shi X, Seto SW, Chang D, Wang H, Zhang S, Chen W, Wang J (2019) Using 3D-UPLC-DAD and a new method-verification by adding mixture standard compounds to determine the fingerprint and eight active components of Naoluoxintong decoction. J Pharm Biomed Anal. 169: 60-69.
  2. Kazzem M, Sun YT, Low M, ^Seto SW, Chang D, Lee S, Suresh H, Khoo CS, Bensoussam A, Kiat H (2019) Chromatographic Analysis and Anti-oxidative Property of Naoxinqing Tablet, a Proprietary Preparation of Diospyros Kaki Leaves. Molecules. 24(6) pii:E1101 (^: Corresponding author)
  3. Wu S, Wang N, He Q, Chang G, Seto SW, Chang D, Liang H (2018) The Establishment of the Method of Cell Biochromatograpy and Analysis of the Active Ingredients from TongQiaoHuoXue Decoction Acting on the Neurocytes. Chem Pharm Bull (Tokyo). 66(10): 983-991
  4. Yang G, Wang N, Seto SW, Chang D, & Liang H. (2018). Hydroxysafflor yellow a protects brain microvascular endothelial cells against oxygen glucose deprivation/reoxygenation injury: Involvement of inhibiting autophagy via class I PI3K/Akt/mTOR signaling pathway. Brain Research Bulletin. 140: 243-257.
  5. Seto SW, Chang D, Kiat H, Wang N, Bensoussan A (2018) Chinese Herbal Medicine as a Potential Treatment of Abdominal Aortic Aneurysm. Frontiers in Cardiovascular Medicine. doi: 10.3389/fcvm.2018.00033.
  6. Li Z, Zhang J, Zou L, Lee SMY, Yang C, Seto SW, Leung GPH (2017) Pro-angiogenic effecets of ilexsaponin A on human umbilical vein endothelial cells in vitro and zebrafish in vivo. Phytomedicine 36: 229-237
  7. Seto SW, Chang D, Ko WM, Zhou X, Kiat H, Bensoussan A, Lee SM, Hoi MP, Steiner GZ, Liu J. (2017) Sailuotong Prevents Hydrogen Peroxide (HO)-Induced Injury in EA.hy926 Cells. Int J Mol Sci 18(1) E95 (First and Corresponding author)
  8. Krishna SM, ^Seto SW, Jose RJ, Li J, Morton SK, Biros E, Wang Y, Nsengiyumva V, Lindeman JH, Loots GG, Rush CM, Craig JM, Golledge J (2017) Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis. Arterioscler Thromb Vasc Biol. 37(3): 553-566 (^: Co-first authorship)
  9. Moran CS, ^Seto SW, Krishna S, Sharma S, Jose RJ, Biros E, Wang Y, Morton SK, Golledge J (2017) Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis. Scientific Reports 7:43079. (^: Co-first authorship)
  10. Krishna SM, Seto SW, Jose R, Li J, Moxon J, Clancy P, Crossman DJ, Norman P, Emeto TI, Golledge J (2017) High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1 promotes angiotensin II induced aortic aneurysm in mice. Clin Sci (Lond). 131(12):1261-1281.

Your browser is not the latest version. If you continue to browse our website, Some pages may not function properly.

You are recommended to upgrade to a newer version or switch to a different browser. A list of the web browsers that we support can be found here